Skip to content

Study · Randomized controlled trial · n = 60 · 2024

7 results

Effects of four-week intranasal oxytocin administration on large-scale brain networks in older adults.

Liu P, Lin T, Fischer H, Feifel D, Ebner NC

Neuropharmacology23 Aug 2024Cited by 2 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study7

7 results from studies that gave the peptide. 7 results from people.

  1. 01HumanRandomized controlled trialMechanism

    In healthy older adults, four weeks of intranasal oxytocin reduced resting-state connectivity of the right insula with the salience network compared with placebo.

    In plain wordsIn healthy older adults, four weeks of nasal oxytocin lowered connectivity between the right insula and the salience network compared with placebo.

    Peptide
    Oxytocin
    Outcome
    DecreaseRight insula connectivity with salience network
    Study

    n = 60

    Comparator
    Placebo
    Outcome group
    Brain and neuronal activity · Nervous system and cognition
    Studied dose
    Dose not stated · intranasal · four weeksAs given in this study (human).

    Source sentences

    Summary
    Chronic IN-OT reduced resting-state functional connectivity (rs-FC) of both the right insula and the left middle cingulate cortex with the salience network but enhanced rs-FC of the left medial prefrontal cortex with the default mode network as well as the left thalamus with the basal ganglia-thalamus network.
    1 context sentence
    Summary · context
    To address these research gaps, 60 generally healthy older adults (mean age = 70.12 years, range = 55-83) were randomly assigned to self-administer either IN-OT or placebo twice daily via nasal spray over four weeks.
  2. 02HumanRandomized controlled trialMechanism

    In healthy older adults, four weeks of intranasal oxytocin reduced resting-state connectivity of the left middle cingulate cortex with the salience network compared with placebo.

    In plain wordsIn healthy older adults, four weeks of nasal oxytocin lowered connectivity between the left middle cingulate cortex and the salience network compared with placebo.

    Peptide
    Oxytocin
    Outcome
    DecreaseLeft middle cingulate connectivity with salience network
    Study

    n = 60

    Comparator
    Placebo
    Outcome group
    Brain and neuronal activity · Nervous system and cognition
    Studied dose
    Dose not stated · intranasal · four weeksAs given in this study (human).

    Source sentences

    Summary
    Chronic IN-OT reduced resting-state functional connectivity (rs-FC) of both the right insula and the left middle cingulate cortex with the salience network but enhanced rs-FC of the left medial prefrontal cortex with the default mode network as well as the left thalamus with the basal ganglia-thalamus network.
    1 context sentence
    Summary · context
    To address these research gaps, 60 generally healthy older adults (mean age = 70.12 years, range = 55-83) were randomly assigned to self-administer either IN-OT or placebo twice daily via nasal spray over four weeks.
  3. 03HumanRandomized controlled trialMechanism

    In healthy older adults, four weeks of intranasal oxytocin enhanced resting-state connectivity of the left medial prefrontal cortex with the default mode network compared with placebo.

    In plain wordsIn healthy older adults, four weeks of nasal oxytocin raised connectivity between the left medial prefrontal cortex and the default mode network compared with placebo.

    Peptide
    Oxytocin
    Outcome
    IncreaseLeft medial prefrontal connectivity with default mode network
    Study

    n = 60

    Comparator
    Placebo
    Outcome group
    Brain and neuronal activity · Nervous system and cognition
    Studied dose
    Dose not stated · intranasal · four weeksAs given in this study (human).

    Source sentences

    Summary
    Chronic IN-OT reduced resting-state functional connectivity (rs-FC) of both the right insula and the left middle cingulate cortex with the salience network but enhanced rs-FC of the left medial prefrontal cortex with the default mode network as well as the left thalamus with the basal ganglia-thalamus network.
    1 context sentence
    Summary · context
    To address these research gaps, 60 generally healthy older adults (mean age = 70.12 years, range = 55-83) were randomly assigned to self-administer either IN-OT or placebo twice daily via nasal spray over four weeks.
  4. 04HumanRandomized controlled trialMechanism

    In healthy older adults, four weeks of intranasal oxytocin enhanced resting-state connectivity of the left thalamus with the basal ganglia-thalamus network compared with placebo.

    In plain wordsIn healthy older adults, four weeks of nasal oxytocin raised connectivity between the left thalamus and the basal ganglia-thalamus network compared with placebo.

    Peptide
    Oxytocin
    Outcome
    IncreaseLeft thalamus connectivity with basal ganglia-thalamus network
    Study

    n = 60

    Comparator
    Placebo
    Outcome group
    Brain and neuronal activity · Nervous system and cognition
    Studied dose
    Dose not stated · intranasal · four weeksAs given in this study (human).

    Source sentences

    Summary
    Chronic IN-OT reduced resting-state functional connectivity (rs-FC) of both the right insula and the left middle cingulate cortex with the salience network but enhanced rs-FC of the left medial prefrontal cortex with the default mode network as well as the left thalamus with the basal ganglia-thalamus network.
    1 context sentence
    Summary · context
    To address these research gaps, 60 generally healthy older adults (mean age = 70.12 years, range = 55-83) were randomly assigned to self-administer either IN-OT or placebo twice daily via nasal spray over four weeks.
  5. 05HumanRandomized controlled trialMechanism

    In healthy older adults, four weeks of intranasal oxytocin did not significantly change between-network resting-state connectivity compared with placebo.

    In plain wordsIn healthy older adults, four weeks of nasal oxytocin did not significantly change connectivity between brain networks compared with placebo.

    Peptide
    Oxytocin
    Outcome
    No significant changeBetween-network connectivity
    Study

    n = 60

    Comparator
    Placebo
    Outcome group
    Brain and neuronal activity · Nervous system and cognition
    Studied dose
    Dose not stated · intranasal · four weeksAs given in this study (human).

    Source sentences

    Summary
    No significant chronic IN-OT effects were observed for between-network rs-FC.
    1 context sentence
    Summary · context
    To address these research gaps, 60 generally healthy older adults (mean age = 70.12 years, range = 55-83) were randomly assigned to self-administer either IN-OT or placebo twice daily via nasal spray over four weeks.
  6. 06HumanRandomized controlled trialMechanism

    In healthy older adults, four weeks of intranasal oxytocin increased selective connectivity of the basal ganglia-thalamus network with the salience network and the default mode network compared with placebo.

    In plain wordsIn healthy older adults, four weeks of nasal oxytocin increased selective connectivity of the basal ganglia-thalamus network with two other brain networks compared with placebo.

    Peptide
    Oxytocin
    Outcome
    IncreaseSelective connectivity of basal ganglia-thalamus network with salience and default mode networks
    Study

    n = 60

    Comparator
    Placebo
    Outcome group
    Brain and neuronal activity · Nervous system and cognition
    Studied dose
    Dose not stated · intranasal · four weeksAs given in this study (human).

    Source sentences

    Summary
    chronic IN-OT increased selective rs-FC of the basal ganglia-thalamus network with the salience network and the default mode network
    1 context sentence
    Summary · context
    To address these research gaps, 60 generally healthy older adults (mean age = 70.12 years, range = 55-83) were randomly assigned to self-administer either IN-OT or placebo twice daily via nasal spray over four weeks.
  7. 07HumanRandomized controlled trialMechanism

    In healthy older adults, some connectivity changes, such as reduced right insula connectivity with the salience network, were more pronounced after chronic than after acute intranasal oxytocin.

    In plain wordsIn healthy older adults, some brain connectivity changes were stronger after four weeks of nasal oxytocin than after a single dose.

    Peptide
    Oxytocin
    Outcome
    MixedChronic versus acute intranasal oxytocin effects on network connectivity
    Study

    n: not reported in source

    Comparator
    Acute intranasal oxytocin
    Outcome group
    Brain and neuronal activity · Nervous system and cognition
    Studied dose
    Dose not stated · intranasal · four weeksAs given in this study (human).

    Source sentences

    Summary
    Directly comparing chronic vs. acute IN-OT, reduced rs-FC of the right insula with the salience network and between the default mode network and the basal ganglia-thalamus network, and greater selective rs-FC of the salience network with the default mode network and the basal ganglia-thalamus networ…
    1 context sentence
    Summary · context
    To address these research gaps, 60 generally healthy older adults (mean age = 70.12 years, range = 55-83) were randomly assigned to self-administer either IN-OT or placebo twice daily via nasal spray over four weeks.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 00:50 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:48 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.